SynPro Overview

  • Founded

  • 2005

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 22

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

SynPro General Information

Description

Manufacturer of pharmaceutical components. The company manufactures DNA and RNA molecules for biotechnology and drug manufacturing companies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
Agilent Technologies
Primary Office
  • Boulder, CO
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynPro Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SynPro‘s full profile, request access.

Request a free trial

SynPro Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial